openPR Logo
Press release

PD-1 and PD-L1 inhibitors- Rising with existing marketed and drugs

08-10-2017 05:19 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

PD-1 and PD-L1 inhibitors- Rising with existing marketed

Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) is the most talked about immuno-oncology target. Programmed Death 1 (PD-1) is an immune inhibitory receptor expressed on several immune cells, particularly cytotoxic T cells. Therapeutics that blocks this interaction has demonstrated promising clinical activity in several tumor types. PD-L1 not only provides the immune escape for tumor cells but also stimulate apoptosis switch on activated T cells.

According to DelveInsight’s report “PD-1 and PD-L1 Inhibitors Competitive Landscape, Pipeline and Market Analysis, 2017”, currently there are about five marketed drugs in this arena and more than 50 products are in the pipeline in various development stages. Products that are in the phase III of development and about to enter the market are – PDR001 (Novartis), REGN2810 (Regeneron), SHR1210 (Incyte). Drugs that are used for this therapy have different molecular types like proteins, fusion proteins, antibody, monoclonal antibody, small molecule, siRNA etc, depending on their derived sources. Also, the route of administration can be subcutaneous, intravenous or oral.

As per the details provided in the report by DelveInsight, companies are working on different technologies for developing drugs in the respective domain, example of such technologies are 3D antigen design technology (Tikcro Technologies), Affimer Technology (Avacta Life Sciences), Avidocin Technology (Merus), Bispecific Fc Domains Technology (Xencor) etc. Currently, maximum products are in pre clinical phase showing the increased interest of companies in the given arena.

DelveInsight’s latest report has covered the complete PD-1 and PD-L1 Inhibitors domain. Complete insight about all the marketed drugs and pipeline products along with the different technologies being used by the companies in the PD-1 and PD-L1 arena is provided. Information about the future products that are about to enter the market and can change the present market scenario, drug profiling of the current marketed products and dormant product information is also covered.

Also, the complete coverage of ASCO 2017 including the latest addition in the market, existing drug achievements and clinical trial results of different drugs is a fringe benefit for the companies and institutes working for the advancement of the respective technology.

Reasons to buy:

• The report provides competitive pipeline landscape of PD-1 and PD-L1 Inhibitors.
• The report provides information about the pipeline products and drug profiling of the marketed drugs, MOA, dormant products.
• The report covers the latest technologies that are being used by different companies.
• Pipeline product coverage based on various stages of development ranging from discovery stage till late stage products.
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making long lasting decision for their businesses.

DelveInsight
New Delhi, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PD-1 and PD-L1 inhibitors- Rising with existing marketed and drugs here

News-ID: 664243 • Views:

More Releases from DelveInsight Business Research

Bartonellosis Market Analysis 2032: Epidemiology, Market Size, Share, Treatment Options, Clinical Trials, Leading Companies & Growth Trends by DelveInsight
Bartonellosis Market Analysis 2032: Epidemiology, Market Size, Share, Treatment …
(New York, USA) DelveInsight's "Bartonellosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Bartonellosis, historical and forecasted epidemiology as well as the Bartonellosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Bartonellosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Bartonellosis market size from 2019 to
Atypical Hemolytic Uremic Syndrome Market Forecasted to Expand by 2032, Projected by DelveInsight | Key Players Include Omeros Corporation, Akari Therapeutics, Alexion Pharmaceuticals, Novartis Pharmaceuticals, Hoffmann-La Roche, and Chugai Pharmaceutical
Atypical Hemolytic Uremic Syndrome Market Forecasted to Expand by 2032, Projecte …
(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and forecasted epidemiology as well as the Atypical Hemolytic Uremic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Atypical Hemolytic Uremic Syndrome market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Hyperhidrosis Market Forecast 2032: Epidemiological Insights, Market Dynamics, Therapeutic Innovations, Clinical Trial Landscape by DelveInsight | Leading Companies - Botanix Pharmaceuticals, GSK Plc, Allergan, Brickell Biotech, Atacama
Hyperhidrosis Market Forecast 2032: Epidemiological Insights, Market Dynamics, T …
(New York, USA) DelveInsight's "Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperhidrosis, historical and forecasted epidemiology as well as the Hyperhidrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The report on the Hyperhidrosis market presents up-to-date treatment practices, emerging drugs, the market share of different therapies, and the present and projected size of the Hyperhidrosis market
Projected Expansion in Chronic Lymphocytic Leukemia Market Forecasted by 2032, DelveInsight Predicts | Loxo Oncology, Oncternal Therapeutics, MingSight Pharmaceuticals, Nurix Therapeutics, Starton Therapeutics, TG Therapeutics, Bristol Myers Squibb, Novar
Projected Expansion in Chronic Lymphocytic Leukemia Market Forecasted by 2032, D …
(New York, USA) DelveInsight's "Chronic Lymphocytic Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Lymphocytic Leukemia, historical and forecasted epidemiology as well as the Chronic Lymphocytic Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Lymphocytic Leukemia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current

All 5 Releases


More Releases for Programmed

First Cryptographic Companion Device Brings Pre-programmed Security to the Autom …
New Delhi, November 17, 2020 — Due to the rise of in-vehicle network connections like Bluetooth® and LTE/5G, today's vehicles host more vulnerabilities than ever before, driving new cybersecurity regulations and specifications for the automotive market. Helping OEMs and their module suppliers simplify the upgrade of existing designs to meet security requirements for future generations, Microchip Technology Inc. (Nasdaq: MCHP) today announced its CryptoAutomotive™ security IC, the TrustAnchor100 (TA100). The
Immune Checkpoint Inhibitors Global Information 2019 : Programmed Death Protein …
Press Release – 29 Jan 2019 Research and Development News -- . . Latest Update "Global Market Study on Immune Checkpoint Inhibitors: Programmed Death Protein 1 (PD-1) Drug Class to Dominate in Terms of Value Through 2026" with Industries Survey | Global Current Growth and Future. ' ' In terms of revenue, the global immune checkpoint inhibitors market is expected to register a CAGR of 14.6% during the forecast period, 2018–2026. The primary objective of the
Programmed Death-1and Programmed Death Ligand-1 Inhibitors Market 2025 | Top Key …
The global programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors market is valued at an estimated $4,926.4 million in 2016, and it is expected to grow at a CAGR of 23.4% during 2017 - 2025. The growth of the global market is largely driven by the increased investment and funding, strong pipeline, and improved safety and efficacy. Download free report sample at: https://www.psmarketresearch.com/market-analysis/pd1-and-pdl1-inhibitors-market/report-sample PD-1 and PD-L1 inhibitors are highly growing immunotherapies
Frequency Synthesizer Market 2018-2023 Key Leaders by Ultra Electronics, Texas, …
Market Scenario: The emerging trend in frequency synthesizer market is increasing usage of frequency synthesizer in mobile phone. Texas Instrument is one of the major player in frequency synthesizer market that has manufactured a range of frequency synthesizer product such as LMX2541 which is an ultra-low noise frequency synthesizer. Qorvo Inc. is one of the prominent player in FS market and has manufactured a wide range of frequency synthesizer and mixers.
Frequency Synthesizer Market- 2018 Key Players by: Ultra Electronics, Texas, Ana …
Market Scenario: The emerging trend in frequency synthesizer market is increasing usage of frequency synthesizer in mobile phone. Texas Instrument is one of the major player in frequency synthesizer market that has manufactured a range of frequency synthesizer product such as LMX2541 which is an ultra-low noise frequency synthesizer. Qorvo Inc. is one of the prominent player in FS market and has manufactured a wide range of frequency synthesizer and mixers.
Data Analytics Market Programmed To Worth 159 Billion USD At 31% of CAGR By 2022
Executive Summary This report studies the global Data Analytics Market, analyzes and researches the Software-Defined Wide Area Network development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, Data Analytics is a statistical method of analyzing and examining very large amount of data and gain an effective outcome. The data which are processed in this method can be